Missense mutations at ALA-10 in the factor IX propeptide: An insignificant variant in normal life but a decisive cause of bleeding during oral anticoagulant therapy

British Journal of Haematology

Volumn 98, Issue 1, 1997, Pages 240-244

  Oldenburg, Johannes ^a,b,c   Quenzel, Ernst Markus ^b   Harbrecht, Uschi ^b   Fregin, Andreas ^a   Kress, Wolfram ^a   Müller, Clemens Rainer ^a   Hertfelder, Hans Jörg ^b   Schwaab, Rainer ^b   Brackmann, Hans Hermann ^b   Hanfland, Peter ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Bleeding; Factor IX; Mutations; Oral anticoagulant therapy; Propeptide

Indexed keywords

ALANINE; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 9; CARBOXYLASE; PHENPROCOUMON; PROTEIN PRECURSOR;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING DISORDER; BLOOD DONOR; CASE REPORT; FEMALE; HUMAN; MALE; MISSENSE MUTATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTHROMBIN TIME; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 8544283812     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.2213036.x     Document Type: Article

References (20)

1. Biggs, R. & Macfarlane, M.G. (1957) Human Blood Coagulation and its Disorders. Blackwell Scientific Publications, Oxford.
2. Chu, K., Wu, S.M., Stanley, T., Stafford, D.W. & High, K.A. (1996) A mutation in the propeptide of factor IX leads to warfarin sensitivity by a novel mechanism. Journal of Clinical Investigation, 98, 1619-1625.
3. Cooper, D.N. & Youssouffian, H. (1988) The CpG dinucleotide and human genetic disease. Human Genetics, 78, 151-155.
4. Fasco, M.J., Hildebrandt, E.F. & Suttie, J.W. (1982) Evidence that warfarin anticoagulant action involves two distinct reductase activities. Journal of Biological Chemistry, 257, 11210-11212.
5. Foster, D.C., Rudinski, M.S., Schach, B.G., Berkner, K.L., Kumar, A.A., Hagen, F.S., Sprecher, C.A., Insley, M.Y. & Davie, E.W. (1987) Propeptide of protein C is necessary for Y-carboxylation. Biochemistry, 26, 7003-7011.
6. Giannelli, F., Green, P.M., Sommer, S.S., Poon, M.C., Ludwig, M., Schwaab, R., Reitsma, P.H., Goossens., M., Yoshioka, A. & Brownlee, G.G. (1996) Haemophilia B (sixth edition): a database of point mutations and short additions and deletions. Nucleic Acids Research, 24, 103-118.
7. Hirsh, J. (1991) Oral anticoagulant drugs. New England Journal of Medicine, 324, 1865-1875.
8. Hull, R., Hirsh, J., Jay, R., Carter, C., England, C., Gent, M., Turpie, A.G.G., McLoughlin, D., Dodd, P., Thomas, T., Raskob, G. & Ockelford, P. (1982) Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. New England Journal of Medicine, 307, 1676-1681.
9. Jorgensen, M.J., Cantor, A.B., Furie, B.C., Brown, C.L., Shoemaker, C.B. & Furie, B. (1987) Recognition site directing vitamin K-dependent gamma-carboxylation resides on the propeptide of factor IX. Cell, 48, 185-191.
10. Kumar, S., Haigh, J.R.M., Tate, G., Boothby, M., Joanes, D.N., Davies, J.A., Roberts, B.E. & Feely, M.P. (1990) Effect of warfarin on plasma concentrations of vitamin K dependent coagulation factors in patients with stable control and monitored compliance. British Journal of Haematology, 74, 82-85.
11. Ludwig, M., Grimm, T., Brackmann, H.H. & Olek, K. (1992) Parental origin of factor IX gene mutations and their distribution in the gene. American Journal of Genetics, 50, 164-173.
12. Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K. & Sekiya, T. (1989) Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphism. Proceedings of the National Academy of Sciences of the United States of America, 86, 2766-2770.
13. Paller, L. & Taberner, D.A. (1982) Dosage and control of oral anticoagulants: an international collaborative survey. British Journal of Haematology, 51, 479-485.
14. Rabiet, M.J., Jorgensen, M.J., Furíe, B. & Furie, B.C. (1987) Effect of propeptide mutations on post-translational processing of factor IX. Journal of Biological Chemistry, 265, 13124-13129.
15. Saour, J.N., Sieck, J.O., Mamo, L.A.R. & Gallus, A.S. (1990) Trail of different intensities of anticoagulation in patients with prosthetic heart valves. New England Journal of Medicine, 322, 428-432.
16. Soute, B.A.M., Ulrich, M.M.W., Watson, D.J., Maddison, J.E., Ebberink, R.U.M. & Vermeer, C. (1992) Congenital deficiency of all vitamin K dependent blood coagulation factors due to a defective vitamin K-dependent carboxylase in Devon Rex cats. Thrombosis and Haemostasis, 57, 521-525.
17. Sutor, A.H., Drages, N. & Niederhoff, H. (1993) Late form of vitamin K deficiency bleeding in Germany. Klinisches Pädiatrie, 207, 89-97.
18. Yoshitake, S., Schach, B.G., Foster, D.C., Davie, E.W. & Kurachi, K. (1985) Nucleotide sequence of the gene for human FIX (antihemophilic factor B). Biochemistry, 24, 2736-3750.
19. Weiss, P., Soff, G.A., Molkin, H. & Seligsohn, E. (1987) Decline of proteins C and S and factor II, VII, IX and X during the initiation of warfarin therapy. Thrombosis Research, 45, 783-790.
20. Willingham, A.K. & Matschiner, J.T. (1974) Changes in phylloquinone epoxidase activity related to prothrombin synthesis and microsomal clotting activity in the rat. Biochemical Journal, 140, 435-441.